ALNY(ALNY)

ALNY

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Next earnings: Jul 30, 2026 · Before open

Signal

Bearish Setup2↓

Price

1↓

Move↓-4.32%Selling pressure

Volume

1→

Volume→0.9× avgNormal activity

Technical

1↓

RSI↓RSI 43Momentum negative

PRICE

Prev Close

309.49

Open

307.46

Day Range295.79 – 311.88

295.79

311.88

52W Range245.96 – 495.55

245.96

495.55

20% of range

VOLUME & SIZE

Avg Volume

1.2M

FUNDAMENTALS

P/E Ratio

74.6x

Premium valuation

EPS (TTM)

—

Div Yield

No dividend

Beta

0.91

Market-like

Quick Read

Trend—Insufficient MA data

Momentum

BULLISH

revenue +83% YoY · 81% gross margin

Valuation

EXPENSIVE

P/E 75x vs ~20x sector

Health

STRONG

CR 3.1 · FCF $4.83/sh

Trend

Momentum

Valuation

Health

Bullish

Composite signal across trend, momentum, valuation & healthSignals from latest available data

Key MetricsTTM

Market Cap$39.51B

Revenue TTM$4.29B

Net Income TTM$577.22M

Free Cash Flow$641.34M

Gross Margin80.9%

Net Margin13.5%

Operating Margin17.5%

Return on Equity98.3%

Return on Assets11.3%

Debt / Equity1.18

Current Ratio3.13

EPS TTM$4.34

Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar

4 strong2 watch

76/100

Liquidity

3.13Strong

Leverage

1.18Watch

Coverage

2.7xWatch

ROE

98.3%Strong

ROIC

19.7%Strong

Cash

$1.7BStrong

ANALYST COVERAGE28 analysts

BUY

▲ +50.5%upside to target

L $351.00

Med $445.50consensus

H $530.00

Buy

2382%

Hold

518%

23 Buy (82%)5 Hold (18%)0 Sell (0%)

Full report →

Stock Health

Composite Score

3 of 4 signals bullish

8/10

Technicals

●

RSI RangeRSI 43 — Bearish momentum

✗

Fundamentals

●

Last EarningsBeat estimates

✓

●

Analyst ConsensusBuy

✓

●

LiquidityCurrent Ratio 3.13 — healthy liquidity

✓

1 signal unavailable — limited data for this stock

Upcoming Events

EEarnings ReportMay 4, 2026

Tomorrow

DEx-Dividend DateJul 31, 2026

In 89 days

PDividend PaymentOct 20, 2026

In 170 days

Research

Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→

FinancialsFull statements →

Technicals

Technical SetupBEARISH

Technicals →

Trend

▼ DowntrendDeath Cross · 50D trails 200D by 5.8%

-19.3% vs SMA 50 · -23.9% vs SMA 200

Momentum

RSI43.2

Momentum fading

MACD-11.05

Below zero — bearish pulse · expanding

Market Position

Price Levels

52W High

$495.6+67.4%

EMA 200

$369.7+24.8%

EMA 50

$364.2+23.0%

Current

$296.1

52W Low

$246.0-16.9%

52-Week RangeNear 52-week low

$246.020th %ile$495.6

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 19 analysts

Full estimates →

Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

Year	Revenue Est.	Rev Gth	EPS Est.	EPS Gth	Range	Analysts
FY2025	$3.8B $3.7B–$3.9B	—	$2.46	—	±37%	High18
FY2026(current)	$5.6B $5.6B–$5.7B	▲ +49.7%	$7.24	▲ +193.6%	±14%	High18
FY2027	$7.4B $6.7B–$9.1B	▲ +31.4%	$10.57	▲ +46.1%	±24%	High19

Range confidence:Tight (high)ModerateWide (low)

Earnings HistoryALNY

Last 8Q

+127.7%avg beat

Beat 7 of 8 quartersMissed 1↑ Estimates rising

+152%

Q3'24

+45%

Q4'24

+110%

Q1'25

+99%

Q2'25

+159%

Q3'25

+417%

Q4'25

-29%

Q1'26

+69%

Q2'26

Beat

Miss

Estimate

Deeper color = bigger beat/miss

* Negative EPS shown at reduced height

Analyst Activity

All ratings →

No recent activity

OppenheimerPerform → Outperform

Aug 4

UPGRADE

Wolfe ResearchNegative → Peer Perform

Aug 4

UPGRADE

Goldman SachsNeutral → Buy

Aug 16

UPGRADE

Goldman SachsNeutral

Feb 16

DOWNGRADE

BMO CapitalMarket Perform → Outperform

May 5

UPGRADE

Piper SandlerOverweight

Jan 3

UPGRADE

Insider Activity

SEC Filings →

0 Buys/6 SellsNet Selling

NET SELLERS$0 bought · $755K sold · 30d window